A comprehensive review of enhanced bioavailability, nutraceutical efficacy, and superior manufacturing quality of Liposomal Curcumin by WBCIL

Abstract:

Curcumin, the principal polyphenolic compound derived from Curcuma longa (turmeric), has garnered considerable scientific interest for its potent anti-inflammatory, antioxidant, and anticancer properties. However, its clinical application has been hindered by poor water solubility, rapid metabolism, and low systemic bioavailability. Liposomal encapsulation has emerged as a promising strategy to overcome these limitations by enhancing curcumin’s solubility, stability, and absorption through phospholipid bilayer carriers. This comprehensive review highlights the advantages of Liposomal Curcumin over conventional formulations, focusing on its superior pharmacokinetics, nutraceutical efficacy, and safety across a wide range of human diseases—including metabolic syndrome, neurodegenerative diseases, osteoarthritis, cardiovascular disorders, and various dermatological conditions.
The review also examines clinical trials and comparative studies that demonstrate significantly improved outcomes with Liposomal Curcumin, even at lower doses. In addition, it outlines the manufacturing excellence of West Bengal Chemical Industries Ltd., Kolkata, India (WBCIL), which employs advanced spray-drying technology and adheres to ISO and GMP-certified protocols to ensure high-quality liposomal formulations.